Bixiye
P76-22 No-Load Miles (Deadhead) Reimbursement Rate for Minnesota Health Care Programs Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1471 - 1480 ee natiijooyinka 3563
Bixiye
P77-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
P75-22 Update to 2023 Renewal Changes Summaries for BP PCC & Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2022
Bixiye
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Warqada dawada ee dhakhtar qoray & farmashiye
KeyRx Drug List Alternatives Effective October 2022